Bao Duong

Title: Innovations by Inventor Bao Duong

Introduction

Bao Duong is a prominent inventor based in San Francisco, CA. He has made significant contributions to the field of immunology, particularly in the development of innovative methods and compositions for enhancing immunoglobulin diversity. With a total of 4 patents to his name, Duong's work is paving the way for advancements in antibody production and therapeutic applications.

Latest Patents

Duong's latest patents include groundbreaking inventions such as "Long germline DH genes and long HCDR3 antibodies." This invention relates to a long DH (LDH) cassette that comprises a recombinant DH construct with at least two DH gene segments. These segments encode at least 10 amino acids of the HCDR3 amino acid sequence, with at least one being a heterologous DH gene segment. Additionally, it involves an immunoglobulin heavy chain locus and a transgenic non-human animal, which can be utilized for producing an immunoglobulin library with long HCDR3 regions. Another notable patent is "Enhanced immunoglobulin diversity," which provides compositions and methods for the enhanced production of immunoglobulin diversity. This invention focuses on making accessible a B cell receptor repertoire that has not been culled by developmental tolerance mechanisms, resulting in transgenic animals, cells, and antibodies.

Career Highlights

Bao Duong is currently associated with Trianni, Inc., where he continues to innovate and contribute to the field of immunology. His work at Trianni, Inc. has been instrumental in advancing the understanding and application of immunoglobulin diversity.

Collaborations

Duong has collaborated with notable colleagues such as Matthias Wabl and Werner Mueller, further enhancing the impact of his research and inventions.

Conclusion

In summary, Bao Duong is a distinguished inventor whose work in immunology has led to significant advancements in antibody production and diversity. His innovative patents and contributions to Trianni, Inc. highlight his commitment to improving therapeutic applications in the field.